Opportunities this week:
- Novo Nordisk (Overweight PT: DKK474 Upside 63%): Commentary relating to growth opportunities in the obesity drug market.
- Kingspan (Overweight PT €84.70 Upside 35%): Commentary on solid Q3 results and outlook. No further detail offered on ADVNSYS IPO.
- Uniphar (Overweight PT: €4.75 Upside 28%): Reaffirming positive outlook on the stock despite recent share price weakness.